Brainstorm Cell Therapeutics Inc. (BCLI)
SG&A Expense Growth
-17.95%
Fiscal year · Period ending:
BCLI SG&A Expense Growth
Latest reported-17.95%period ending
Latest reported-17.95%period ending
BCLI FY SG&A Growth (YoY) (0.00% → -17.95%)
Latest values, visible window
High-resolution chart · PNG
BCLI sg&a expense growth history
Annual fiscal periods. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | SG&A Expense Growth |
|---|---|
| -17.9494% | |
| -34.1438% | |
| -1.5921% | |
| 16.7885% | |
| -0.5452% | |
| 61.3766% | |
| 0.4679% | |
| 43.461% | |
| 41.9696% | |
| -21.0204% | |
| 35.4096% | |
| 26.0828% | |
| 20.1945% | |
| -20.7256% | |
| 42.8109% | |
| -1.5934% | |
| -3.6832% | |
| -45.5184% | |
| 39.7433% | |
| 0% | |
| 0% | |
| 5,143.2685% | |
| 29.6755% | |
| 53.0356% | |
| 0% |